Kiara Tulla
Surgery · New Orleans, LANPI 1073907283
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,079 of the $1,529 with a category attached, or 70.5%. Organox Ltd accounts for 70.5% of it on its own, with 7 other manufacturers making up the rest. That places this record below the midpoint for surgery clinicians in LA, where the typical reported total is $1,529.
Across 11 payments — averaging $139.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organox Ltd$1K
- Dilon Technologies, Inc.$137
- Acera Surgical, Inc.$110
- Johnson & Johnson$66
- Veloxis Pharmaceuticals, Inc.$57
- Davol Inc.$53
- plus $28 from 2 others
What the payments were for
- Travel & lodging$1,07971%
- Food & beverage$45129%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organox Ltd | 2 | $1,079 |
| Dilon Technologies, Inc. | 1 | $137 |
| Acera Surgical, Inc. | 1 | $110 |
| Johnson & Johnson | 1 | $66 |
| Veloxis Pharmaceuticals, Inc. | 2 | $57 |
| Davol Inc. | 2 | $53 |
| Intercept Pharmaceuticals, Inc. | 1 | $14 |
| Gilead | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- METRA$1,079
- HemoBlast Bellows$137
- Restrata Wound Matrix$110
How this compares
$1,529 in reported general payments places this provider in the 50th percentile of 381 surgery providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Valganciclovir Hcl | 61 | $11,659 |
| Fluconazole | 46 | $1,251 |
| Famotidine | 60 | $308 |
| Nystatin | 12 | $290 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 76 | $210 |
| Prednisone | 30 | $132 |
Paid to pharmacies, not to this prescriber.
Other surgery in New Orleans
- Carlos GalvaniNew Orleans$352K
- Joseph BuellNew Orleans$186K
- Michael CookNew Orleans$84K
- Douglas SlakeyNew Orleans$81K
- Ian HodgdonNew Orleans$38K
- Shauna LevyNew Orleans$33K
- Adwoa Opoku-BoatengNew Orleans$30K
- Ari CohenNew Orleans$28K
- Mohamed-Aly BakeerNew Orleans$27K
- William KethmanNew Orleans$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.